fyi
LOVENOX® (enoxaparin sodium injection) is a unique chemical entity in a class of antithrombotic agents known as low-molecular-weight heparins (LMWH). LOVENOX® was approved in the United States and Canada in 1993, and it has been available in Europe since 1987. LOVENOX® is the only low-molecular-weight heparin in the United States approved by the Food and Drug Administration in 7 approved indications for the prophylaxis and treatment of thromboembolic disease.
The #1 selling low-molecular-weight heparin in the world, the safety and efficacy of LOVENOX® has been demonstrated for more than 15 years treating over 100 million patients in 96 countries.